In response to difficulties in obtaining pyrimethamine, the primary drug used to treat toxoplasmosis, IDSA in conjunction with HIVMA and the Pediatric Infectious Diseases Society created a new online resource
with information for obtaining the drug through a compound pharmacy or through Turing Pharmaceutical’s Daraprim Direct Program. The societies also continue to monitor member challenges obtaining the medication for patients through the Daraprim Access Blog
. If you have experienced difficulty obtaining pyrimethamine for a patient or for your institution, please let us know by reporting publicly through the blog or by emailing HIVMA
In related news, the U.S. House of Representatives’ Full Committee on Oversight and Government Reform held a hearing on February 4 on Developments in the Prescription Drug Market: Oversight
that included witnesses from the Food and Drug Administration, Turing Pharmaceuticals LLC and Valeant Pharmaceuticals International, Inc. IDSA
sent letters to the Committee in advance of the hearing and issued a statement
. During the hearing, Representative Elijah Cummings, ranking member of the committee, acknowledged IDSA and HIVMA and thanked the organizations for their input to the committee.